U.S. flag

An official website of the United States government

NM_020374.4(FERRY3):c.1360C>T (p.Arg454Ter) AND Intellectual disability, autosomal recessive 66

Germline classification:
Pathogenic/Likely pathogenic (4 submissions)
Last evaluated:
Jan 3, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000723367.5

Allele description [Variation Report for NM_020374.4(FERRY3):c.1360C>T (p.Arg454Ter)]

NM_020374.4(FERRY3):c.1360C>T (p.Arg454Ter)

Gene:
FERRY3:FERRY endosomal RAB5 effector complex subunit 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12p13.32
Genomic location:
Preferred name:
NM_020374.4(FERRY3):c.1360C>T (p.Arg454Ter)
Other names:
C12ORF4, ARG454TER
HGVS:
  • NC_000012.12:g.4500218G>A
  • NG_051648.1:g.43291C>T
  • NM_001304811.2:c.1360C>T
  • NM_001346153.2:c.1231C>T
  • NM_001346155.2:c.1231C>T
  • NM_001346156.2:c.841C>T
  • NM_001346157.2:c.712C>T
  • NM_001352962.2:c.508C>T
  • NM_020374.4:c.1360C>TMANE SELECT
  • NP_001291740.1:p.Arg454Ter
  • NP_001333082.1:p.Arg411Ter
  • NP_001333084.1:p.Arg411Ter
  • NP_001333085.1:p.Arg281Ter
  • NP_001333086.1:p.Arg238Ter
  • NP_001339891.1:p.Arg170Ter
  • NP_065107.1:p.Arg454Ter
  • NC_000012.11:g.4609384G>A
  • NM_020374.2:c.1360C>T
  • NM_020374.3:c.1360C>T
  • NR_144379.2:n.1339C>T
  • NR_144380.2:n.1012C>T
  • NR_144382.2:n.809C>T
Protein change:
R170*; ARG454TER
Links:
OMIM: 616082.0003; dbSNP: rs749969789
NCBI 1000 Genomes Browser:
rs749969789
Molecular consequence:
  • NR_144379.2:n.1339C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_144380.2:n.1012C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_144382.2:n.809C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_001304811.2:c.1360C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001346153.2:c.1231C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001346155.2:c.1231C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001346156.2:c.841C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001346157.2:c.712C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001352962.2:c.508C>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_020374.4:c.1360C>T - nonsense - [Sequence Ontology: SO:0001587]
Observations:
1

Condition(s)

Name:
Intellectual disability, autosomal recessive 66
Synonyms:
Mental retardation, autosomal recessive 66
Identifiers:
MONDO: MONDO:0032605; MedGen: C4748732; OMIM: 618221

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000854767OMIM
no assertion criteria provided
Pathogenic
(Dec 22, 2021)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV001245382SIB Swiss Institute of Bioinformatics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Feb 14, 2020)
unknowncuration

PubMed (2)
[See all records that cite these PMIDs]

SCV001443032Institute of Human Genetics, University of Leipzig Medical Center
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Mar 1, 2020)
biparentalclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV0020587483billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jan 3, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

PMID:28097321

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedbiparentalyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyes1not providednot provided1not providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedcuration
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Diagnostic Yield and Novel Candidate Genes by Exome Sequencing in 152 Consanguineous Families With Neurodevelopmental Disorders.

Reuter MS, Tawamie H, Buchert R, Hosny Gebril O, Froukh T, Thiel C, Uebe S, Ekici AB, Krumbiegel M, Zweier C, Hoyer J, Eberlein K, Bauer J, Scheller U, Strom TM, Hoffjan S, Abdelraouf ER, Meguid NA, Abboud A, Al Khateeb MA, Fakher M, Hamdan S, et al.

JAMA Psychiatry. 2017 Mar 1;74(3):293-299. doi: 10.1001/jamapsychiatry.2016.3798.

PubMed [citation]
PMID:
28097321

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From OMIM, SCV000854767.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In 2 sisters with a nonsyndromic intellectual developmental disorder (MRT66; 618221) from a consanguineous Turkish family, Reuter et al. (2017) identified homozygosity for a c.1360C-T transition (c.1360C-T, NM_020374.2) in the C12ORF4 gene, resulting in a premature termination codon substituting for the arginine at codon 454 (R454X). This variant was not identified in gnomAD.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From SIB Swiss Institute of Bioinformatics, SCV001245382.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (2)

Description

This variant is interpreted as likely pathogenic for Mental retardation, autosomal recessive 66. The following ACMG Tag(s) were applied: PM2, PVS1-Strong.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Institute of Human Genetics, University of Leipzig Medical Center, SCV001443032.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Review of the variants reported in Reuter et al., 2017, PMID: 28097321: PVS1,PM2,PM3_Supporting

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1biparentalyesnot providednot providednot providednot providednot providednot providednot provided

From 3billion, SCV002058748.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS).The variant has been reported at least twice as pathogenic/likely pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000592164, PMID:28097321). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000025, PM2_M). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

Last Updated: Oct 8, 2024